openPR Logo
Press release

AI in Drug Discovery Market Set to Reach USD 10.93 Billion by 2031 | Transparency Market Research

12-12-2023 03:24 PM CET | Health & Medicine

Press release from: Transparency Market Research

AI in Drug Discovery Market

AI in Drug Discovery Market

The latest research study released by Transparency Market Research on "AI in Drug Discovery Market Forecast to 2023-2031 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the AI in Drug Discovery industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial data.

AI in Drug Discovery market is estimated to attain a valuation of US$ 10.93 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 36.1% during the forecast period, 2023-2031

Get a Sample Copy of the AI in Drug Discovery Market Research Report (Use Corporate Mail Id for Quick Response) -https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=82867

"Connect with our team of research specialists and unlock the optimal solution for driving your business growth"

This study does a thorough examination of the market and offers insights based on an industry SWOT analysis. The report on the AI in Drug Discovery Market provides access to critical information such as market growth drivers, market growth restraints, current market trends, the market's economic and financial structure, and other key market details.

Furthermore, The report provides a detailed understanding of the market segments which have been formed by combining different prospects such as types, applications, and regions. Apart from this, the key driving factors, restraints, potential growth opportunities, and market challenges are also discussed in the report.

Updated Version of Sample Report Included:

Detailed industry forecast
Brief Introduction to the research report.
Additional information on company participants
Customized reports and analyst assistance are available upon request.
Recent market developments and potential future growth opportunities
Personalized regional/country reports upon request
New data sources are being integrated.
Increased focus on data privacy and security
Increased collaboration and co-creation

Inquire more about this report before purchase - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=82867

The report covers extensive competitive intelligence which includes the following data points:

- Business Overview

- Business Model

- Financial Data

- Financial - Existing

- Financial - Funding

- Product/Service Segment Analysis and specification

- Recent Development and Company Strategy Analysis

- SWOT Analysis

Competitor Analysis:

The significant players operating in the global AI in Drug Discovery market are

Top Key players in AI in drug discovery market are Exscientia, GNS Healthcare, Cloud Pharmaceuticals, Inc., Benevolent AI, PathAI, Inc., BlackThorn Therapeutics, Insilico Medicine, Notable Labs, Standigm, Recursion Pharmaceuticals, and BioSymetrics

Market Segmentation -

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2023-2031.

This Report lets you identify the opportunities in AI in Drug Discovery Market by means of a region:

North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)

Have Any Query? Ask To Analyst: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=82867

Key Features of the AI in Drug Discovery Market Report: -

➤ Analyze competitive developments such as expansions, deployments, new product launches, and market acquisitions.

➤ Examine the market opportunities for stakeholders by identifying higher growth sections.

➤ To study and analyze the global AI in Drug Discovery industry status and forecast including key regions.

➤ An in-depth analysis of key product segments and application spectrum, providing strategic recommendations to incumbents and new entrants to give them a competitive advantage over others.

➤ It provides a comprehensive analysis of key regions of the industry as well as a SWOT analysis and Porter's Five Forces analysis to provide a deeper understanding of the market.

➤ It helps you make strategic business decisions and investment plans.

Research Methodology

The report has its roots definitely set in thorough strategies provided by proficient data analysts. The research methodology involves the collection of information by analysts only to have them studied and filtered thoroughly in an attempt to provide significant predictions about the market over the review period. The research process further includes interviews with leading market influencers, which makes the primary research relevant and practical. The secondary method gives a direct peek into the demand and supply connection. The market methodologies adopted in the report offer precise data analysis and provide a tour of the entire market. Both primary and secondary approaches to data collection have been used. In addition to these, publicly available sources such as annual reports, and white papers have been used by data analysts for an insightful understanding of the market.

Reasons to Buy The AI in Drug Discovery Market Report: -

1.Regional report analysis highlighting the consumption of products/services in a region also shows the factors that influence the market in each region.

2.Reports provide opportunities and threats faced by suppliers in the AI in Drug Discovery industry around the world.

The report shows regions and sectors with the fastest growth potential.

3.A competitive environment that includes market rankings of major companies, along with new product launches, partnerships, business expansions, and acquisitions.

4.The report provides an extensive corporate profile consisting of company overviews, company insights, product benchmarks, and SWOT analysis for key market participants.

5.This report provides the industry's current and future market outlook on the recent development, growth opportunities, drivers, challenges, and two regional constraints emerging in advanced regions.

More Trending Reports by Transparency Market Research -

MicroRNA Market

https://www.globenewswire.com/en/news-release/2023/03/30/2638271/0/en/MicroRNA-Market-Size-to-Reach-USD-15-5-Bn-by-2033-TMR-Study.html

Thermoplastic Composites Market

https://www.globenewswire.com/en/news-release/2023/03/30/2637539/0/en/Thermoplastic-Composites-Market-to-Grow-at-a-6-CAGR-from-2021-2031-reaching-US-27-Billion-As-per-TMR-Study.html

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Nikhil Sawlani

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AI in Drug Discovery Market Set to Reach USD 10.93 Billion by 2031 | Transparency Market Research here

News-ID: 3325034 • Views:

More Releases from Transparency Market Research

Cloud Artificial Intelligence (AI) Solutions Market Poised for Exponential Growth, Projected to Reach $254.6 Billion by 2031
Cloud Artificial Intelligence (AI) Solutions Market Poised for Exponential Growt …
The Global Cloud Artificial Intelligence (AI) Solutions Market (클라우드 인공지능(AI) 솔루션 시장) is set for remarkable growth, with projections indicating a leap from $38.1 billion in 2022 to an estimated $254.6 billion by 2031. This represents a robust compound annual growth rate (CAGR) of 24.1% over the forecast period of 2023 to 2031. The rapid expansion of the market reflects the transformative potential of cloud-based AI technologies across diverse industries. Cloud-based
Global Smart Agriculture Market Poised for Significant Growth, Expected to Exceed $39 Billion by 2031: TMR Analysis
Global Smart Agriculture Market Poised for Significant Growth, Expected to Excee …
The Global Smart Agriculture Market (スマート農業市場), valued at approximately US$ 10.02 billion in 2020, is set to experience robust expansion, with an anticipated compound annual growth rate (CAGR) of 13.30% from 2021 to 2031. Market analysts project that the sector will surpass US$ 39.02 billion by the end of the forecast period, driven by advancements in technology and increasing adoption of digital solutions in farming practices. Download Sample PDF from Here-
Real-Time Flood Monitoring & Warning System Market Expected to Grow at 6.2% CAGR, Reaching $359.5 Million by 2031: TMR Analysis
Real-Time Flood Monitoring & Warning System Market Expected to Grow at 6.2% CAGR …
The Global Real-Time Flood Monitoring and Warning System Market (실시간 홍수 모니터링 및 경고 시스템 시장), valued at over USD 184.1 million in 2020, is set to witness substantial growth over the next decade. According to industry analysts, the market is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2021 to 2031, ultimately surpassing USD 359.5 million by the end of the forecast period. The increasing
Global Asset and Wealth Management Market Set for Explosive Growth, Projected to Reach $11.8 Billion by 2031: TMR Analysis
Global Asset and Wealth Management Market Set for Explosive Growth, Projected to …
The Global Asset and Wealth Management Market (資産および資産管理市場), valued at US$ 3.5 billion in 2021, is projected to expand at a robust CAGR of 13.0% from 2022 to 2031, reaching a market value of US$ 11.8 billion by the end of the forecast period. The asset and wealth management industry is witnessing rapid evolution, spurred by the integration of advanced technologies, regulatory changes, and shifting investor demographics. As technology plays an

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug